Lonza | LONN - Operating Profit


Lonza reported CHF673M in Operating Profit for its fiscal semester ending in June of 2025.





Operating Profit Change Date
Akzo Nobel EUR 251M 3M Jun/2026
Alcon AG USD 44M 253M Jun/2026
Almirall EUR 71.55M 41.32M Jun/2026
AstraZeneca USD 3.16B 3.95B Jun/2026
BASF EUR 1.43B 31M Jun/2026
Bayer EUR 827M 2.7B Jun/2026
Beiersdorf EUR 504M 312M Dec/2025
Covestro EUR -324M 5.72B Dec/2025
Demant DKK 2.12B 35M Jun/2026
Fresenius EUR 719M 118M Jun/2026
Fresenius Medical Care EUR 537.27M 269.27M Jun/2026
Geberit CHF 134.1M 65.8M Dec/2025
Genmab DKK 407M 182M Jun/2026
Givaudan CHF 610M 149M Dec/2025
GlaxoSmithKline GBP 2.6B 312M Jun/2026
GN Store Nord DKK 58M 126M Jun/2026
Hikma Pharmaceutical USD 348M 161M Dec/2025
Johnson Matthey GBP 198M 56M Jun/2026
Merck EUR 1.1B 51M Jun/2026
Novartis USD 4.75B 515M Jun/2026
Philips EUR 610M 308M Jun/2026
Roche Holding CHF 11.46B 1.91B Jun/2026
Sanofi EUR 2.38B 449M Jun/2026
Sika AG CHF 724.9M 73.2M Dec/2025
Smith & Nephew USD 505M 65M Jun/2026
Solvay EUR 73M 45M Jun/2026
UCB EUR 1.29B 571M Dec/2025